Jate, Romulo E.

HRN: 26-93-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2025
04/13/2025
IV
500 Mg
Q8hrs
Hepatic Mass Prob Malignant; T/C Partial Bowel Obstruction
Waiting Final Action 
04/06/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/06/2025
04/13/2025
IV
1.5g
Q8hrs
Hepatic Mass Prob Malignant; T/C Partial Bowel Obstruction
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: